Accuray Incorporated (0H8I.L)
USD 1.36
(1.15%)
USD 1.36
(1.15%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.54 Million USD | -67.51% |
| 2022 | -9.28 Million USD | -73.56% |
| 2021 | -5.34 Million USD | 15.27% |
| 2020 | -6.31 Million USD | -264.91% |
| 2019 | 3.82 Million USD | 123.29% |
| 2018 | -16.43 Million USD | 31.25% |
| 2017 | -23.89 Million USD | 19.2% |
| 2016 | -29.57 Million USD | -15.98% |
| 2015 | -25.5 Million USD | 36.57% |
| 2014 | -40.2 Million USD | -13.43% |
| 2013 | -35.44 Million USD | 63.59% |
| 2012 | -97.36 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | -15.54 Million USD | -67.51% |
| 2023 Q2 | -9.62 Million USD | -224.05% |
| 2023 Q3 | -6.34 Million USD | 34.08% |
| 2023 Q4 | 3.38 Million USD | 153.41% |
| 2023 Q1 | -2.96 Million USD | -16.16% |
| 2022 Q4 | -2.55 Million USD | -526.71% |
| 2022 FY | -9.28 Million USD | -73.56% |
| 2022 Q3 | 599 Thousand USD | 131.96% |
| 2022 Q2 | -1.87 Million USD | 65.61% |
| 2022 Q1 | -5.44 Million USD | -57.85% |
| 2021 Q1 | -1.02 Million USD | 90.73% |
| 2021 Q2 | 179 Thousand USD | 117.41% |
| 2021 Q3 | -1.04 Million USD | -684.36% |
| 2021 Q4 | -3.45 Million USD | -230.02% |
| 2021 FY | -5.34 Million USD | 15.27% |
| 2020 Q3 | -390 Thousand USD | -108.18% |
| 2020 Q1 | 402 Thousand USD | 364.47% |
| 2020 Q4 | -11.09 Million USD | -2744.1% |
| 2020 Q2 | 4.76 Million USD | 1086.32% |
| 2020 FY | -6.31 Million USD | -264.91% |
| 2019 Q4 | -152 Thousand USD | -105.79% |
| 2019 Q1 | -9.35 Million USD | -568.29% |
| 2019 Q2 | 10.71 Million USD | 214.47% |
| 2019 FY | 3.82 Million USD | 123.29% |
| 2019 Q3 | 2.62 Million USD | -75.49% |
| 2018 Q4 | -1.4 Million USD | -18.24% |
| 2018 Q3 | -1.18 Million USD | 74.48% |
| 2018 Q2 | -4.64 Million USD | 49.6% |
| 2018 Q1 | -9.2 Million USD | -873.15% |
| 2018 FY | -16.43 Million USD | 31.25% |
| 2017 Q1 | -9.38 Million USD | -78.53% |
| 2017 FY | -23.89 Million USD | 19.2% |
| 2017 Q4 | -946 Thousand USD | 89.31% |
| 2017 Q3 | -8.85 Million USD | -87.58% |
| 2017 Q2 | -4.71 Million USD | 49.7% |
| 2016 Q4 | -5.25 Million USD | -4.49% |
| 2016 Q3 | -5.02 Million USD | 46.32% |
| 2016 Q2 | -9.36 Million USD | 5.61% |
| 2016 Q1 | -9.92 Million USD | -37.73% |
| 2016 FY | -29.57 Million USD | -15.98% |
| 2015 Q4 | -7.2 Million USD | -1053.31% |
| 2015 Q1 | -13.02 Million USD | -132.61% |
| 2015 Q3 | 756 Thousand USD | 112.54% |
| 2015 Q2 | -6.02 Million USD | 53.73% |
| 2015 FY | -25.5 Million USD | 36.57% |
| 2014 FY | -40.2 Million USD | -13.43% |
| 2014 Q4 | -5.6 Million USD | -88.74% |
| 2014 Q1 | -21.65 Million USD | -120.72% |
| 2014 Q3 | -2.96 Million USD | 70.31% |
| 2014 Q2 | -9.99 Million USD | 53.85% |
| 2013 Q1 | -15.53 Million USD | 17.0% |
| 2013 Q3 | -4.66 Million USD | 14.26% |
| 2013 Q4 | -9.8 Million USD | -110.27% |
| 2013 FY | -35.44 Million USD | 63.59% |
| 2013 Q2 | -5.44 Million USD | 64.97% |
| 2012 Q4 | -18.71 Million USD | 40.02% |
| 2012 Q3 | -31.2 Million USD | -22.3% |
| 2012 Q2 | -25.51 Million USD | 0.0% |
| 2012 FY | -97.36 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 88.644% |
| Align Technology, Inc. | 445.05 Million USD | 103.493% |
| Elevance Health Inc. | 5.98 Billion USD | 100.26% |
| AxoGen, Inc. | -21.71 Million USD | 28.417% |
| Boston Scientific Corporation | 1.59 Billion USD | 100.976% |
| CVS Health Corporation | 8.34 Billion USD | 100.186% |
| Cardinal Health, Inc. | 852 Million USD | 101.825% |
| Centene Corporation | 2.7 Billion USD | 100.575% |
| DaVita Inc. | 691.53 Million USD | 102.248% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 100.297% |
| Hologic, Inc. | 789.5 Million USD | 101.969% |
| Humana Inc. | 2.48 Billion USD | 100.625% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 101.84% |
| Laboratory Corporation of America Holdings | 418 Million USD | 103.719% |
| Masimo Corporation | 81.5 Million USD | 119.074% |
| McKesson Corporation | 3 Billion USD | 100.518% |
| Patterson Companies, Inc. | 185.93 Million USD | 108.361% |
| Quest Diagnostics Incorporated | 854 Million USD | 101.82% |
| ResMed Inc. | 1.02 Billion USD | 101.523% |
| Henry Schein, Inc. | 416 Million USD | 103.737% |
| Teladoc Health, Inc. | -220.36 Million USD | 92.946% |
| Universal Health Services, Inc. | 717.79 Million USD | 102.166% |
| Veeva Systems Inc. | 525.7 Million USD | 102.957% |
| Baxter International Inc. | 2.65 Billion USD | 100.585% |
| Becton, Dickinson and Company | 1.48 Billion USD | 101.048% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.865% |
| Danaher Corporation | 4.2 Billion USD | 100.37% |
| Stryker Corporation | 3.16 Billion USD | 100.491% |
| Medtronic plc | 3.67 Billion USD | 100.423% |